Howard L. Li

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Tau pathology spreads between anatomically-connected regions of the brain and is modulated by a LRRK2 mutation”.

Tau pathology spreads between anatomically-connected regions of the brain and is modulated by a LRRK2 mutation

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.13.337857

N/A

0DataRank · unranked

3 citations

Eli J. Cornblath, Howard L. Li, Lakshmi Changolkar, Bin Zhang, Hannah J. Brown +6 more

Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor

Science Advances(2021)10.1126/sciadv.abg6677

N/A

0DataRank · unranked

71 citations

Howard L. Li, Lakshmi Changolkar, Bin Zhang, Hannah J. Brown, Ronald J. Gathagan +6 more

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology spread

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.06.561190

N/A

0DataRank · unranked

1 citations

Julia K. Brynildsen, Connor M. Webb, Howard L. Li, Cheryl E. G. Leyns, Lakshmi Changolkar +10 more

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Journal of Clinical Investigation(2024)10.1172/jci176567

N/A

0DataRank · unranked

26 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Howard L. Li, Aanika Balaji +38 more

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

Translational Neurodegeneration(2024)10.1186/s40035-024-00403-2

N/A

0DataRank · unranked

23 citations

Julia K. Brynildsen, Connor M. Webb, Howard L. Li, Cheryl E. G. Leyns, Lakshmi Changolkar +10 more

Investigating peripheral blood biomarkers of immune checkpoint inhibitor associated fatigue.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2571

N/A

0DataRank · unranked

0 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Aanika Warner, Kabeer Munjal +15 more

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

Nature Communications(2025)10.1038/s41467-025-58512-z

N/A

0DataRank · unranked

27 citations

Soren Charmsaz, Hua‐Ling Tsai, Khaled Aziz, Daniel Shu, Kabeer Munjal +25 more

Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009734

N/A

0DataRank · unranked

18 citations

Soren Charmsaz, Howard L. Li, Hua‐Ling Tsai, Ludmila Danilova, Kabeer Munjal +29 more

Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1055

N/A

0DataRank · unranked

6 citations

Soren Charmsaz, Elsa Hallab, Mike Fang, Chester Kao, Madelena Brancati +19 more

Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events

New England Journal of Medicine(2025)10.1056/nejmc2513984

N/A

0DataRank · unranked

3 citations

Howard L. Li, Chetan Bettegowda, Kenneth W. Kinzler, Nickolas Papadopoulos, Mark Yarchoan +2 more